Zvelt Therapeutics Inc.

Columbus, OH

UEI
NJ63VKWADYL3
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1275 Kinnear Rd, Columbus, OH 43212, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Zvelt Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Novel adipose targeted gene therapy for lipodystrophy - project summary lipodystrophy includes a heterogeneous group… Grant · R42DK138551 National Institute of Diabetes and Digestive and Kidney Diseases $1,931,890
Novel adipose targeted gene therapy for lipodystrophy - project summary lipodystrophy includes a heterogeneous group… Grant · R41DK138551 National Institute of Diabetes and Digestive and Kidney Diseases $293,842

Quick answers

What is Zvelt Therapeutics Inc.'s UEI?

Zvelt Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is NJ63VKWADYL3.

Where is Zvelt Therapeutics Inc. located?

Zvelt Therapeutics Inc.'s physical address in SAM.gov is 1275 Kinnear Rd, Columbus, OH 43212, USA.

Is Zvelt Therapeutics Inc. registered in SAM.gov?

Yes. Zvelt Therapeutics Inc.'s SAM.gov registration is active through June 18, 2027.

What is Zvelt Therapeutics Inc.'s most recent federal award?

Zvelt Therapeutics Inc.'s most recent federal grant award is Novel adipose targeted gene therapy for lipodystrophy - project summary lipodystrophy includes a heterogeneous group… (R42DK138551), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 9, 2025.

On GovTribe

See Zvelt Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login